Investigating the Leishmania donovani sacp Gene and Its Role in Macrophage Infection and Survival in Mice
-
Published:2022-11-18
Issue:11
Volume:7
Page:384
-
ISSN:2414-6366
-
Container-title:Tropical Medicine and Infectious Disease
-
language:en
-
Short-container-title:TropicalMed
Author:
Paulini KaylaORCID,
Lypaczewski PatrickORCID,
Zhang Wen-WeiORCID,
Perera Dilhan J.ORCID,
Ndao Momar,
Matlashewski Greg
Abstract
The protozoan parasite Leishmania donovani is a causative agent of the neglected tropical disease known as visceral leishmaniasis, which can be lethal when untreated. Studying Leishmania viru-lence factors is crucial in determining how the parasite causes disease and identifying new targets for treatment. One potential virulence factor is L. donovani’s abundantly secreted protein: secreted acid phosphatase (SAcP). Whole-genome analysis revealed that the sacp gene was present in three copies in wild type L. donovani. Using CRISPR-Cas9 gene editing; we generated a sacp gene knockout termed LdΔSAcP, which demonstrated a loss of both the SAcP protein and an associated reduction in secreted acid phosphatase activity. Genome sequencing confirmed the precise dele-tion of the sacp gene in LdΔSAcP and identified several changes in the genome. LdΔSAcP demonstrated no significant changes in promastigote proliferation or its ability to infect and survive in macrophages compared to the wildtype strain. LdΔSAcP also demonstrated no change in murine liver infection; however, survival was impaired in the spleen. Taken together these results show that SAcP is not necessary for the survival of promastigotes in culture but may support long-term survival in the spleen. These observations also show that the use of CRISPR gene editing and WGS together are effective to investigate the function and phenotype of complex potential drug targets such as multicopy genes.
Funder
Canadian Institutes of Health Research
R. Howard Webster Foundation
Foundation of the McGill University Health Center
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Immunology and Microbiology
Reference41 articles.
1. Leishmaniasis;Lancet,2018
2. CDC (2022, January 26). For D.C. and CDC–Leishmaniasis. Epidemiology & Risk Factors, Available online: https://www.cdc.gov/parasites/leishmaniasis/epi.html.
3. CDC (2022, January 26). For D.C. and CDC-Leishmaniasis. Biology, Available online: https://www.cdc.gov/parasites/leishmaniasis/biology.html.
4. From Infection to Vaccination: Reviewing the Global Burden, History of Vaccine Development, and Recurring Challenges in Global Leishmaniasis Protection;Expert Rev. Vaccines,2021
5. Virulence Factors of Leishmania Parasite: Their Paramount Importance in Unraveling Novel Vaccine Candidates and Therapeutic Targets;Life Sci.,2022
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献